Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_assertion description "[In 2006, TAR DNA-binding protein 43 (TDP-43), a highly conserved nuclear protein, was identified as the major disease protein in amyotrophic lateral sclerosis (ALS) and in the most common variant of frontotemporal lobar degeneration (FTLD), FTLD-U, which is characterized by cytoplasmic inclusions that stain positive for ubiquitin but negative for tau and alpha-synuclein.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_assertion evidence source_evidence_literature NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_assertion SIO_000772 20234357 NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_assertion wasDerivedFrom befree-20150227 NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_assertion wasGeneratedBy ECO_0000203 NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.
- befree-20150227 importedOn "2015-02-27" NP786026.RAiBocLNTeOrZYW5v32LyzK-GDL983ukpGmcleeaDsJZE130_provenance.